Side-by-side comparison of AI visibility scores, market position, and capabilities
Delinea is a privileged access management platform delivering secrets management, privilege elevation, and session controls across cloud, on-premise, and hybrid environments.
Delinea is a privileged access management (PAM) company headquartered in Redwood City, California, formed in 2021 through the merger of Thycotic and Centrify — two established PAM vendors whose combination created one of the largest independent players in the privileged access security market. The merger was backed by TPG Capital and brought together Thycotic's Secret Server vault and cloud PAM capabilities with Centrify's identity-centric privileged access controls and zero trust architecture, creating a unified platform that addresses the full spectrum of PAM use cases: vaulting and rotating privileged credentials, enforcing just-in-time privilege elevation, recording and auditing privileged sessions, and managing machine and application secrets at scale.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.